Ikonisys S.A. (EPA: ALIKO)

Market Cap	16.10M
Revenue (ttm)	471.50K
Net Income (ttm)	-2.70M
Shares Out	11.26M
EPS (ttm)	-0.26
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,301
Open	1.470
Previous Close	1.470
Day's Range	1.460 - 1.480
52-Week Range	1.250 - 1.800
Beta	0.66
Analysts	n/a
Price Target	n/a
Earnings Date	Apr 29, 2025

About Ikonisys

Ikonisys S.A., a cell-based diagnostics company, develops, produces, and markets medical diagnostic products for early and accurate detection of cancer diseases in the United States and Europe. It offers Ikoniscope Robotic Microscopes, including Ikoniscope20 that provides automated slide handling, slide scanning, and real-time image capture and analysis; and Ikoniscope20max that automates the fluorescence microscopy solution. The company also provides oncoFISH bladder that allows scanning and analysis of cells from a voided urine sample; oncoFI...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2021
• Employees: 10
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALIKO

Financial Performance

In 2023, Ikonisys's revenue was 448,557, a decrease of -27.28% compared to the previous year's 616,866. Losses were -2.27 million, -7.38% less than in 2022.